戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  66.4 +/- 12.2 y) for uHCC (36 uninodular, 5 multinodular, 36 diffuse) with (90)Y TARE (41 resin, 36
2 acteristic CT findings of massively enlarged multinodular adrenal glands.
3                 Eleven patients had enlarged multinodular adrenal glands: Nodules were 0.1-5.5 cm.
4 ing syndrome and with bilateral nonpigmented multinodular adrenal hyperplasia.
5  applies to tumors presenting with a diffuse/multinodular as well as solitary nodule pattern.
6  of 56 cases (27%) in which the HCC was in a multinodular, bilobar form (T4), sufficient discordance
7 iltrative), focality (solitary oligonodular, multinodular), disease distribution (unilobar, bilobar),
8  patients referred for a diffuse goiter or a multinodular gland, ultrasonography detected discrete no
9 d higher D2 to D1 mRNA ratios than normal or multinodular glands suggesting differential regulation o
10  with an inherited tumor syndrome, featuring multinodular goiter (MNG) and rare pediatric-onset lesio
11  hyperthyroidism (Graves disease, GD), toxic multinodular goiter (TMNG), and toxic thyroid adenoma (T
12 ten display thyroid abnormalities, including multinodular goiter and follicular adenomas, and are at
13  situations for autonomous nodules and toxic multinodular goiter and remains a safe and effective tre
14                                Treatment for multinodular goiter includes dietary iodine supplementat
15  of 123] vs 24.3% [70 of 288], P < .001) and multinodular goiter or thyroid nodule (40.7% [50 of 123]
16 land disease (OR, 7.63; 95% CI, 3.49-16.69), multinodular goiter or thyroid nodule (OR, 1.82; 95% CI,
17 lian tumor susceptibility syndrome: familial multinodular goiter with schwannomatosis.FUNDINGCanadian
18 ith non-medullary thyroid carcinoma (TC) and multinodular goiter, before and after treatment with rad
19 ractive thyroid gland (Graves disease, toxic multinodular goiter, toxic adenoma).
20  clinical practice in nontoxic uninodular or multinodular goiter.
21 131)I to treat hyperthyroidism and euthyroid multinodular goiter.
22 ed by any type of hyperthyroidism--eg, toxic multinodular goitre or solitary autonomously functioning
23 ndrome is Graves' disease, followed by toxic multinodular goitre, and solitary hyperfunctioning nodul
24 topathological similarities with human toxic multinodular goitre, which has been associated with acti
25  = 1.81; 95% CI = 1.21-2.71; P = 0.004), and multinodular (&gt;3) HCC (HR = 1.79; 95% CI = 1.21-2.63; P
26 mice, with N-nitrosodiethylamine resulted in multinodular HCC with steatotic features and associated
27 lar adenomas, 10 papillary carcinomas, or 10 multinodular hyperplasias.
28  surgery performed for a malignant tumor and multinodular intrathoracic goiters.
29  practice widely applied among patients with multinodular, large, and macrovascular invasive HCC, pro
30 umber: uninodular tumors 2 cm or smaller and multinodular or uninodular tumors 2 cm or larger.
31 n contrast, patients in the study group with multinodular or uninodular tumors larger than 2 cm had w
32 ), nodular (OR = 0.76, p = 3.1 x 10(-5)) and multinodular (OR = 0.69, p = 3.9 x 10(-5)) goiters, and
33 r, clinical decompensation of cirrhosis, and multinodular tumor are independent prognostic predictors
34  a transient viral hepatitis and resulted in multinodular tumorigenesis within 5 to 8 weeks.
35 e for patients with asymptomatic noninvasive multinodular tumors in intermediate-stage disease.
36  total beta-catenin protein were observed in multinodular tumors independent of beta-catenin mutation